Frank A. Lattanzio PhD, Director Microscopy Facility

Faculty

Cardiovascular, cancer and ophthalmic pharmacology, including (1) treatment of ischemia and reperfusion injury (2) novel neuroprotectants for treatment of glaucoma and free radical scavengers for radiation- and chemo-protection during cancer therapy (3) development of lacritin as a treatment for dry eye (4) anti-angiogenic compounds for treatment of cancer and age related macular degeneration (5) jellyfish Aurelia aurita as a model for ototoxicity and Parkinson’s disease (6) use of optical probes and development of biomedical instruments, such as non-invasive, passive microwave devices to monitor brain temperature and telemetric intraocular pressure monitoring.

757.446.5636

Lewis Hall